Cell Line Description:
HCC1007BL is a B lymphoblastoid cell line initiated by Epstein-Barr virus (EBV)-transformation of peripheral blood lymphocytes obtained from the same patient as the breast carcinoma cell line HCC1008. HCC1008 was initiated from a 67 year old Black female with a TNM stage IIA, grade 3 metastatic carcinoma; metastatic site: lymph node. DNA isolated from the cell line HCC1008 is available as ATCC CRL-2320D.
Quality Control Specifications
- > 100 kb in size by agarose gel electrophoresis
- No RNA detected in the agarose gel
- A260/A280 ratio ≥ 1.8
- Tested and verified for PCR amplification and restriction digestion.